Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 473-476

  Natta, Rajatanavin ^a   Somsak, Tanratanakorn ^b   Wisuttida, Taechotirote ^b   Laor, Limtakul ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN;

ADULT; ARTICLE; ASIA; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE; RETROSPECTIVE STUDY; SKIN PIGMENTATION; SOLAR ENERGY; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO; VOMITING;

EID: 0041856230     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)01484-1     Document Type: Article

References (18)

1. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Hypomelanoses and hypermelanoses. In: Freedberg IM, Disen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al, editors. Dermatology in general medicine. New York: McGraw-Hill; 1999. p. 945-1017.
2. Nordlund JJ, Grimes PE, Halder RM, Minus HR. Guidelines of care for vitilito. J Am Acad Dermatol 1996;35:620-6.
3. Pasricha JS, Khera V. Effect of prolonged treatment with levam - sole on vitiligo with limited and slow-spreading disease. Int J Dermatol 1994;33:584-7.
4. Juhlin L, Olsson MJ. Improvement of vitiligo after oral treatment with Vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 1997;77:460-2.
5. Kim SM, Lee HS, Hann SK. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Int J Dermatol 1999; 38:546-50.
6. Parsad D, Saini R, Verma N. Combination of PUVA sol and topical calcipotriol in vitiligo. Dermatology 1998;197:167-70.
7. Seiter S, Ugurel S, Tilgen W, Reinhold U. Use of high-dose methylprednisolone therapy in patients with progressive and stable vitiligo. Int J Dermatol 2000;39:624-7.
8. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. A systemic review of autologous transplantation methods in vitiligo. Arch Dermato 1998;134:1543-9.
9. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol 1998;134:1532-40.
10. Halder RM, Battle E, Smith EM. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol 1995;131:734-5.
11. Morison WL, Baughman RD, Day RM, Forbes PD, Honigsmann H, Krueger GG, et al. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol 1998;134:595-8.
12. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Engl J Med 1997;336:1041-5.
13. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997;133:1525-8.
14. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band UVB (TL 01) radiation therapy. J Am Acad Dermatol 2000;42:245-53.
15. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001;44:999-1003.
16. Kent G, Al' Abadie M. Psychologic effects of vitiligo: a critical incidence analysis. J Am Acad Dermatol 1996;35:895-8.
17. Porter JR, Hill-Beuf A, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986;15:220-4.
18. Sterenborg HJ, van Weelden H, van der Leun JC. The dose response relationship for tumorigenesis by UV radiation in the region 311-312 nm. J Photochem Photobiol B 1988;2:179-94.